The research & development by business enterprise, pharmaceutical industry in current ppp $ in Canada is now 572.86 million, marking a 130.98 million (29.6%) increase compared to 2020.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Canada
No matching regions
Similar regions to Canada
Business R&D pharmaceutical in current PPP $
More indicators for Canada
Government R&D in security as % of government support
2.59%
+0.27%
(2021)
Higher-education-finacing R&D financed by general university in local currency
38,070.00M
+380.00M
(2023)
R&D financed by rest of the world in local currency
51,800.00M
+1,210.00M
(2023)
Government R&D financed by rest of the world in local currency
10.00M
0.00M
(2023)
Business R&D financed by rest of the world in local currency
50,210.00M
+1,190.00M
(2023)
Non-profit R&D growth rate
-14.23%
-23.4%
(2022)
Canada Business R&D pharmaceutical in current PPP $ between 1994 and 2021
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2021 | 572.86M | +130.98M |
| 2020 | 441.88M | +36.25M |
| 2019 | 405.63M | -49.40M |
| 2018 | 455.03M | +2.17M |
| 2017 | 452.86M | +41.94M |
| 2016 | 410.92M | +10.29M |
| 2015 | 400.63M | +25.13M |
| 2014 | 375.50M | +34.81M |
| 2013 | 340.69M | -23.28M |
| 2012 | 363.97M | -53.80M |
| 2011 | 417.77M | -128.95M |
| 2010 | 546.73M | -11.40M |
| 2009 | 558.12M | +12.29M |
| 2008 | 545.83M | -258.13M |
| 2007 | 803.96M | -95.76M |
| 2006 | 899.72M | +21.66M |
| 2005 | 878.07M | -39.94M |
| 2004 | 918.01M | +52.27M |
| 2003 | 865.74M | -82.00M |
| 2002 | 947.74M | +213.22M |
| 2001 | 734.52M | +105.97M |
| 2000 | 628.55M | +139.95M |
| 1999 | 488.60M | +83.46M |
| 1998 | 405.13M | +37.38M |
| 1997 | 367.76M | -11.44M |
| 1996 | 379.19M | +31.67M |
| 1995 | 347.52M | +38.46M |
| 1994 | 309.06M |